Characterizing and Communicating Uncertainty in the Assessment of Benefits and Risks of Pharmaceutical Products: Workshop Summary by Institute of Medicine, Forum on Drug Discovery Development and, Board on Health Sciences Policy

Characterizing and Communicating Uncertainty in the Assessment of Benefits and Risks of Pharmaceutical Products: Workshop Summary

Institute of Medicine, Forum on Drug Discovery Development and, Board on Health Sciences Policy

150 pages missing pub info (editions)

nonfiction health technology challenging informative medium-paced
Powered by AI (Beta)
Loading...

Description

Despite the extensive body of evidence that informs regulatory decisions on pharmaceutical products, significant uncertainties persist, including the underlying variability in human biology, factors associated with the chemistry of a drug, and lim...

Read more

Community Reviews

Loading...

Content Warnings

Loading...